Nurse Practitioner Program year 2025 Reported 2023–2025 Source: CMS Open Payments, 2026 publication

Catherine Gregg

Nurse Practitioner Upper St Clair, PA Nurse Practitioner

NPI 1043958374 CMS profile 11385305

2589 Washington Rd, Upper St Clair, PA 15241

Open in the dashboard

General payments

$1,817

93 records reported · program years 2023–2025

Research payments

$0

Paid to them · None reported · program years 2023–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Catherine Gregg of Upper St Clair, PA is reported in the CMS Open Payments database as having received $1,817 across 93 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Nurse Practitioner profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $384 21
2024 General $1,114 54
2023 General $320 18

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Catherine Gregg
  • Nurse Practitioner median
  • Middle half of Nurse Practitioner
  • National median

In program year 2025, general payments to Catherine Gregg were reported at $384. Among 41,044 Nurse Practitioner profiles paid that year, the median was $174 and the middle half received between $55 and $557.

Show as a table
Year Catherine Gregg Nurse Practitioner median Middle half National median
2019 $0 $50 $22–$97 $163
2020 $0 $40 $16–$108 $114
2021 $0 $135 $40–$426 $132
2022 $0 $152 $48–$470 $149
2023 $320 $166 $54–$529 $160
2024 $1,114 $173 $55–$556 $164
2025 $384 $174 $55–$557 $169

Breakdown

Who paid General payments · program years 2023–2025
  1. AbbVie, Inc. $560 36 payments
  2. Genzyme Corporation $540 26 payments
  3. Pfizer Inc. $184 16 payments
  4. Phathom Pharmaceuticals, Inc. $172 5 payments
  5. Inspire Medical Systems, Inc. $134 3 payments
  6. Sanofi-Aventis U.S. LLC $100 1 payment
  7. Regeneron Healthcare Solutions, Inc. $95 4 payments
  8. Stryker Corporation $19 1 payment
  9. CSL Behring $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2023–2025
  1. Food and Beverage $1,717 92 payments
  2. Education $100 1 payment
Products named General payments · program years 2023–2025
  1. DUPIXENT Immunology $661 28 payments
  2. QULIPTA $451 29 payments
  3. UBRELVY $218 19 payments
  4. NURTEC ODT $184 16 payments
  5. ZAVZPRET $149 14 payments
  6. VOQUEZNA Gastroenterology $142 2 payments
  7. INSPIRE $134 3 payments
  8. DUPIXENT Inflammation And Immunology $95 4 payments
  9. VOQUEZNA Gastroenterology $30 3 payments
  10. AUDION ET DILATION SYSTEM $19 1 payment
  11. Other $14 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 33 drugs

Part D claims

1,255

Median for Nurse Practitioner: 389

Drug cost

$19,081

Median for Nurse Practitioner: $21,885

Branded share of claims

11.1%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ciprofloxacin-Dexamethasone Ciprofloxacin Hcl/Dexameth Brand 24 $3,088
Fluocinolone Acetonide Oil Generic 57 $2,109
Ipratropium Bromide Generic 72 $1,991
Azelastine Hcl Generic 49 $1,780
Fluticasone Propionate Generic 183 $1,725
Ofloxacin Generic 62 $1,143
Omeprazole Generic 97 $978
Famotidine Generic 80 $887
Pantoprazole Sodium Generic 64 $859
Synthroid Levothyroxine Sodium Brand 15 $845

The 10 drugs with the highest cost, of 33 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 18 billing codes

Paid by Medicare

$24,281

Medicare's payments for the services billed

Medicare patients

328

Average age 77

Services billed

866

178 women, 150 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 70%
Arthritis 45%
Ischemic heart disease 24%
Diabetes 23%
Atrial fibrillation 20%
Cancer 19%
Osteoporosis 19%
Heart failure 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 7 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DUPIXENT
  • GENZYME CORPORATION $203
  • SANOFI-AVENTIS U.S. LLC $100
  • Regeneron Healthcare Solutions, Inc. $26
$329 — —
QULIPTA
  • AbbVie, Inc. $218
$218 — —
VOQUEZNA
  • Phathom Pharmaceuticals, Inc. $172
$172 — —
UBRELVY
  • AbbVie, Inc. $94
$94 — —
NURTEC ODT
  • PFIZER INC. $67
$67 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 7 in the dashboard with a free account

Records

93 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record